Market Tracker

10/20 4:45pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

7.79
Data as of Oct 20
 -0.09 / -1.14%
Today’s Change
5.84
Today|||52-Week Range
11.47
+3.32%
Year-to-Date

Today’s Trading

Previous close7.88
Today’s open7.85
Day’s range7.74 - 8.04
Volume186,722
Average volume (3 months)421,601
Market cap$338.2M
Dividend yield--
Data as of 3:59pm ET, 10/20/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+100.45%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book9.42

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.48+4.76%
VVUSVIVUS Inc+0.09+2.68%
DERMDermira Inc+0.31+2.19%
PGNXProgenics Pharmaceut...+0.12+2.56%
Data as of 3:59pm ET, 10/20/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.44
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts